• Updated

The TUXEDO-3 trial is the first study to evaluate the intracranial and extracranial efficacy and safety of a novel anti-cancer drug in patients with breast or lung cancer and active brain metastases, and leptomeningeal disease from solid tumors.These results were presented as an oral presentationat the American Society of Clinical Oncology (ASCO) 2025 annual meeting, with select results simultaneously published in Nature Medicine.The findings highlight HER3-DXd as a potential novel treatment for patients with secondary central nervous system involvement.

  • Updated

MIDDLETOWN, Ohio, May 30, 2025 /PRNewswire/ -- EpicQuest Education Group International Limited (NASDAQ: EEIQ), ("EpicQuest Education", "EEIQ" or the "Company"), a provider of higher education for domestic and international students in the US, Canada and the UK, today announced that on May 27, 2025, it closed a private placement offering of 4,500,000 ordinary shares and warrants to purchase 13,500,000 ordinary shares at a combined purchase price of $0.40 per share and accompanying warrants for gross proceeds of $1.8 million. The warrants are immediately exercisable at an exercise price of $0.48 per share, and expire one year after the issuance date.

  • Updated

AKRON, Ohio, May 30, 2025 /PRNewswire/ -- The Goodyear Tire & Rubber Company (NASDAQ: GT) said today it will participate in a fireside chat during TD Cowen's 9th Annual Future of The Consumer Conference on June 4, 2025, at 8:45 a.m. ET.

  • Updated

CHICAGO, Ill., May 30, 2025 /PRNewswire/ -- Vaniam Group™, a leader in medical communications, is proud to announce the launch of Vaniam Intelligence™, our platform that integrates proprietary artificial intelligence (AI) with human expertise to transform how biopharma companies develop strategies and make decisions. Designed to deliver actionable insights early, Vaniam Intelligence empowers clients to stay ahead in a competitive and rapidly evolving landscape. 

  • Updated

LOS ANGELES, May 30, 2025 /PRNewswire/ -- Leading smart ring brand RingConn has officially expanded its retail presence through a partnership with Target, one of the largest and most influential retailers in the United States. The brand's flagship RingConn Gen 2 Smart Ring, along with accessories, is now available for purchase on Target.com, marking a strategic entry into the U.S. mainstream consumer market.